Aleks Engel

Investment Partner

Overview

Gender
male
Investor Type
Investment Partner

Aleks joined Novo A/S in September 2014 as Asset Director in Novo Large Investments taking part in managing and developing the growing portfolio of investments.

Prior to joining Novo, Aleks was employed as Vice President in Baxter International in Illinois and Shanghai, working with global M&A licensing, growth strategies, investment prioritization and go-to-market planning. Other previous employments include Pfizer Global Research and Development, Thomson Scientific & Healthcare and McKinsey & Company (all U.S.A.).


Aleks holds a Ph.D. in Biochemical Engineering (1999) and a M.Sc. in Chemical Engineering Practice (1995) from Massachusetts Institute of Technology.


Aleks is a member of the board of directors of Symphogen A/S and Xellia Pharmaceuticals ApS.

Jobs

Number of Current Jobs
1
Aleks Engel has 1 current jobs including Member Board Of Directors at AFYX Therapeutics , .
Organization Name Title At Company Start Date End Date
AFYX Therapeutics Member Board Of Directors Sep 1, 2019 Detail